Consumer staples have drawn renewed investor attention as defensive positioning, pricing power, and dividend durability take center stage across recent market cycles. These two exchange-traded funds (ETFs) are frequently compared because they appear to offer the same thing: broad access to essential-goods companies. In practice, however, IYK and XLP differ meaningfully in index construction, sector purity, cost, and liquidity. Understanding those structural differences is essential for any investor weighing an ETF comparison in the staples space, because small variations in holdings and fees can translate into noticeably different sector exposure and fund performance over time. I also checked this using Tickeron’s AI Screener to see how the funds line up against peers.
IYK is a passively managed fund that seeks to track the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, which measures U.S. consumer staples companies drawn from the broader Russell 1000 universe. The fund typically holds roughly 55 securities, making it a concentrated but not ultra-narrow portfolio. Its largest positions include PG (Procter & Gamble), KO (Coca-Cola), PM (Philip Morris International), PEP (PepsiCo), and CVS (CVS Health), with additional exposure to MO (Altria), MCK (McKesson), MDLZ (Mondelez), CL (Colgate-Palmolive), and MNST (Monster Beverage).
A distinguishing feature of IYK is that it is not a pure staples fund. Food, beverage, and tobacco represent roughly 55% of assets, and household and personal products add about 21%, but healthcare equipment and services account for roughly 13%—largely through pharmaceutical distributors—and materials contribute a small sliver. The fund charges an expense ratio of 0.38%, which is relatively high for a passive sector product. From what I see, that healthcare overlay adds a layer of complexity worth monitoring.
XLP is a passively managed fund that seeks to replicate the Consumer Staples Select Sector Index, which is drawn from consumer staples companies within the S&P 500 using the Global Industry Classification Standard (GICS). The fund holds roughly 38 securities, making it more concentrated at the index level but purer in its sector mandate. Its top holdings include WMT (Walmart), COST (Costco Wholesale), PG (Procter & Gamble), KO (Coca-Cola), and PM (Philip Morris International), followed by MDLZ (Mondelez), PEP (PepsiCo), MO (Altria), CL (Colgate-Palmolive), and TGT (Target).
Unlike IYK, XLP is effectively a pure consumer staples vehicle, with roughly 98–100% of assets in the staples sector and no material healthcare or materials overlay. Its expense ratio is 0.08%, among the lowest in the category, and it is one of the largest and most heavily traded staples ETFs, offering deep liquidity and tight spreads.
Both funds operate in the consumer staples sector, a defensive equity category defined by relatively steady demand for food, beverages, household goods, and personal care products. In recent market cycles, staples have benefited from a flight toward quality and predictable cash flows as investors reassess valuations in more cyclical and technology-heavy areas. At the same time, the sector faces pressure from input-cost inflation, changing consumer behavior toward value and private-label goods, and the rise of weight-loss drugs, which have weighed on sentiment for certain packaged-food names. Tobacco holdings add a regulatory and litigation overhang, while staples retailers have benefited from resilient consumer traffic and membership-driven revenue. These forces affect both funds but in different proportions given their divergent holdings. One thing that stands out is how the retail tilt in XLP may respond differently to consumer trends than IYK’s mix.
Across recent weeks and months, the relative performance of IYK and XLP has been shaped by their structural differences rather than the staples label they share. IYK’s meaningful allocation to healthcare distributors and its heavier tobacco weighting can introduce a different earnings cycle and regulatory sensitivity than XLP’s retail-heavy, pure-staples construction. XLP’s outsized exposure to Walmart and Costco has tended to anchor the fund around large-cap consumer traffic trends, while IYK is more influenced by pricing power in tobacco and the economics of pharmaceutical distribution. On a risk basis, both funds carry low beta relative to the broad market, but IYK historically shows somewhat lower market sensitivity, reflecting its defensive healthcare and tobacco mix. Cost drag is another key differentiator: with a materially higher expense ratio, IYK faces a structural headwind in fund performance relative to XLP over time. I’m watching this closely as fee differences compound over longer periods.
In my own research process, Tickeron’s AI Screener has become a useful step when evaluating sector ETFs like these. It helps filter for technical patterns, fundamentals, and relative performance metrics across thousands of securities, making it easier to spot how IYK and XLP stack up against each other and the broader staples group. The tool’s customizable filters for industry, volatility, and AI-driven signals streamline the comparison without replacing personal judgment on holdings and costs.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 67 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +2.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 32 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 62 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples